Below are links to research studies in heart and blood vessels. If you are thinking of taking part in one, please talk to your doctor.

• Atrial Fibrillation - A trail to investigate the cost and clinical effectiveness of Amiodarone versus Beta Blockade for new onset atrial fibrillation in ICU

• Abatacept (CTLA4-Ig) for the treatment of relapsing, non-severe, granulomatosis with polyangiitis (Wegener's)

• BRITISH:Using CMR scar as risk indication tool in NICM and severe LVSD

• Cardiovascular magnetic resonance imaging in healthy volunteers

• Comparing two Treatments for Slow Heart Rates

• EASY-AS - A Randomised Controlled Trial of Early surgery in severe ASYmptomatic Aortic Stenosis

• EMBRACE Study - Randomised Controlled study of Physical Exercise Intervention in Breast Cancer Patients at Risk of Anthracycline-induced Cardiomyopathy

• EVIDENCE - Evaluating Diuretics in Normal Care: a cluster randomised evaluation of hypertension prescribing policy.

• Fast Field Cyclic-Magnetic Resonance Imaging (FFC-MRI): A New Diagnostic that Reveals Acutely Inflamed Coronary Artery Plaques by Detecting Fat Dysfunction

• Further Development of Fast Field Cycling MRI Machine to perform Cardiac Imaging

• HERMES: Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation.

• Investigating the effectiveness of PET Scans to predict heart attacks

• Is There a Genetic Predisposition for Acute Stress-Induced (Takotsubo)Cardiomyopathy?

• Platelet Transfusions - best transfusion threshold below which platelet transfusions should be given to patients who need an invasive procedure in ICU

• Periodontal health in patients with acute myocardial infarction

• POC-ET - Point of Care Evaluation of high-sensitivity cardiac Troponin

• STARR STUDY - Establishing the incidence of Tako-tsubo cardiomyopathy in Scotland.

• TEMPEST - A randomised, double-blind, placebo-controlled, phase 2 evaluation of the efficacy and mechanism of trientine in patients with hypertrophic cardiomyopathy.

• The HEart iN Renal dIsease (HENRI) study V1.0 - Treatment decision-making in myocardial infarction for people with advanced kidney disease: A qualitative study.

• Trialling Tezepelumab treatment in Eosinophilic Granulomatosis with Polyangiitis (EGPA)